With global trends showing an increase in maternal age and pregnancy-related complications, precision imaging for prenatal diagnostics and rapid clinical decision-making have become increasingly vital. As a result, women’s health diagnostic systems are evolving beyond basic fetal evaluations to encompass early complication prediction, maternal health assessments, and holistic wellness.

Aligning with these global clinical needs, Samsung Medison showcased the HERA Z Series at the 34th International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) World Congress held in London from September 4 to 7.

Under the banner “HERA Z, The Flagship Series,” Samsung Medison presented its vision for next-generation diagnostic solutions, showcasing the series as a unified platform that spans the full spectrum of women’s healthcare.

The HERA Z Series serves as a comprehensive diagnostic platform designed to support maternal and fetal care alike, featuring AI-assisted automated measurement tools and dedicated neonatal probes.

Advanced AI Workflows and Next-Generation Imaging Architecture

The newly launched HERA Z10 inherits the proven AI-based workflow solutions of the flagship HERA Z20 while incorporating advanced beamforming technology designed to maximize image clarity. This expanded lineup empowers healthcare institutions to choose from a more versatile selection of premium systems within the HERA Z Series, perfectly tailored to their unique clinical environments and operational goals.

Engineered specifically to streamline clinical workflows through artificial intelligence, the HERA Z10 delivers significant efficiency gains:

• Live ViewAssist: According to joint clinical research conducted with Professor Giuseppe Rizzo and Professor Daniele Di Mascio of Sapienza University of Rome — founding members of ISUOG — Live ViewAssist reduces scan times during mid-trimester detailed ultrasound examinations by up to 52%.
• EzStructure: Reduces manual manipulation for key measurement parameters by up to 71%, significantly enhancing measurement consistency and objectivity while dramatically lowering clinician fatigue.

Enhanced AI Diagnostic Assistance for High-Risk Pregnancies

The system also introduces enhanced AI-assisted diagnostic capabilities for complex clinical scenarios:

• MV-Flow 3D: Captures microvascular blood flow at high resolution, providing critical clinical value for managing high-risk pregnancies, aiding in the diagnosis of placenta accreta and evaluation of  abnormal uterine or umbilical cord blood vessels.
• FibroidVue: Utilizes AI to automatically segment, visualize, and measure the uterus, endometrium, and uterine fibroids, facilitating intuitive and efficient clinical assessments.

Interactive Experiences and Digital Synergy at ISUOG

At the ISUOG Congress, Samsung Medison hosted interactive experience zones highlighting the core value proposition of the HERA Z Series. Under the theme “ART OF ULTRASOUND,” an AI digital art exhibition reinterpreting fetal ultrasound images drew strong interest from attendees. Additionally, Samsung Medison demonstrated an integrated digital solution using Galaxy Tab devices, allowing clinicians and mothers to seamlessly monitor fetal growth records throughout the pregnancy journey.

“The launch of the HERA Z10 is more than just an addition to our product lineup; it represents a major milestone in extending the distinctive clinical value of the HERA Z Series to a wider range of healthcare settings,” said Jihyun Kim, Head of CX Team at Samsung Medison. “By leveraging premium imaging technology and unparalleled AI workflows, we remain committed to meeting diverse clinical needs and driving brand innovation so that healthcare professionals worldwide can select custom-fit solutions optimized for their unique practice environments.”